THE VALUE OF THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE (ASDAS) IN EVALUATING DISEASE ACTIVITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS
Romanian Journal of Rheumatology · 2015
DOI: 10.37897/rjr.2015.3.8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Rheumatology, 2015. Verfasst von Laura Muntean und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
To evaluate the clinical value of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in assessing disease activity in axial SpA patients in comparison with conventional clinical measures of disease activity in daily clinical practice. Patients and methods. Eighty-five patients with axial SpA were included in a cross-sectional study. Disease activity was assessed by Bath Ankylosing Spondylitis Disease Activity (BASDAI) score, ASDAS score with C-reactive protein (ASDAS-CRP), ASDAS score with erythrocyte sedimentation rate (ASDAS-ESR), patient’s global assessment of disease activity (PtGA), CRP and ESR, while physical function was evaluated by the Bath Ankylosing Spondylitis Functional Index (BASFI). The correlation between different markers of disease activity and functional capacity and ASDAS scores were determined. Patients were grouped into high and low disease activity states according to PtGA scores, CRP levels and BASDAI scores. We compared the discriminating ability of the two ASDAS versions and the conventional clinical measures of disease activity in differentiating between patients with high and low disease activity by using standardized mean differences and receiver operating characteristic (ROC) curve analysis.
Results
ASDAS-CRP and ASDAS-ESR showed good correlation with BASDAI (r = 0.84 and 0.72, respectively), PtGA (r = 0.82 and 0.74, respectively), and BASFI (r = 0.74 and 0.70, espectively). Moderate correlations were seen between the two ASDAS versions and ESR and CRP (r ranged from 0.43 to 0.70). The ASDAS versions had higher discriminating capacities as compared to conventional patient-reported measures (BASDAI and PtGA) and objective markers of disease activity (CRP and ESR). The ASDAS-CRP performed better than ASDAS-ESR. Both ASDAS versions and BASDAI had high areas under the curve (AUC) according to PtGA and CRP levels (AUC ranged from 0.66 to 0.92, all p < 0.01). The calculated cut-offs for discriminating between disease activity states in our axSpA patients were relatively similar to the Assessment of Spondyloarthritis International Society (ASAS) endorsed cut-offs.
Conclusions
ASDAS versions had higher discriminating ability in patients with axSpA in terms of high and low disease activity states than conventional measures. These findings suggest that ASDAS is a valid and reliable assessment tool for axial SpA patients in daily clinical practice.
Zitieren
APA
Muntean, L., Valeanu, M., Lungu, A., Felea, I., Filipescu, I., Tamas, M. M., Balaj, R., Ghib, L., Siao-Pin, S., & Rednic, S. (2015). THE VALUE OF THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE (ASDAS) IN EVALUATING DISEASE ACTIVITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS. Romanian Journal of Rheumatology. https://doi.org/10.37897/rjr.2015.3.8
Vancouver
Muntean L, Valeanu M, Lungu A, Felea I, Filipescu I, Tamas MM, et al. THE VALUE OF THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE (ASDAS) IN EVALUATING DISEASE ACTIVITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS. Romanian Journal of Rheumatology. 2015. doi:10.37897/rjr.2015.3.8
BibTeX
@article{Muntean2015,
author = {Muntean, Laura and Valeanu, Madalina and Lungu, Andreea and Felea, Ioana and Filipescu, Ileana and Tamas, Maria Magdalena and Balaj, Raluca and Ghib, Linda and Siao-Pin, Simon and Rednic, Simona},
title = {THE VALUE OF THE ANKYLOSING SPONDYLITIS DISEASE ACTIVITY SCORE (ASDAS) IN EVALUATING DISEASE ACTIVITY IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS},
journal = {Romanian Journal of Rheumatology},
year = {2015},
doi = {10.37897/rjr.2015.3.8}
}
EUVIMED